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Abstract
Background: Human endogenous retroviruses (HERVs) are repetitive sequences derived from ancestral germ-line infections
by exogenous retroviruses and different HERV families have been integrated in the genome. HERV-Fc1 in chromosome X
has been previously associated with multiple sclerosis (MS) in Northern European populations. Additionally, HERV-Fc1 RNA
levels of expression have been found increased in plasma of MS patients with active disease. Considering the North-South
latitude gradient in MS prevalence, we aimed to evaluate the role of HERV-Fc1on MS risk in three independent Spanish
cohorts.
Methods: A single nucleotide polymorphism near HERV-Fc1, rs391745, was genotyped by Taqman chemistry in a total of
2473 MS patients and 3031 ethnically matched controls, consecutively recruited from: Northern (569 patients and 980
controls), Central (883 patients and 692 controls) and Southern (1021 patients and 1359 controls) Spain. Our results were
pooled in a meta-analysis with previously published data.
Results: Significant associations of the HERV-Fc1 polymorphism with MS were observed in two Spanish cohorts and the
combined meta-analysis with previous data yielded a significant association [rs391745 C-allele carriers: pM-H = 0.0005; ORM-H
(95% CI) = 1.27 (1.11–1.45)]. Concordantly to previous findings, when the analysis was restricted to relapsing remitting and
secondary progressive MS samples, a slight enhancement in the strength of the association was observed [pM-H = 0.0003,
ORM-H (95% CI) = 1.32 (1.14–1.53)].
Conclusion: Association of the HERV-Fc1 polymorphism rs391745 with bout-onset MS susceptibility was confirmed in
Southern European cohorts.
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Introduction
Multiple sclerosis (MS) is a complex autoimmune disorder
characterized by multifocal demyelination, axonal loss and
neurodegeneration within the central nervous system of genetically
susceptible individuals [1]. Clinical symptoms vary according to
the location of the neurological lesions and patients often suffer an
initial clinical isolated syndrome followed by a series of recurring-
remitting events with neurological impairment (RRMS). Usually
patients recover their near normal neurological function after each
episode, but with the course of the disease an irreversible
progression of clinical disability termed secondary progression
(SPMS) may appear and early therapeutic intervention is claimed
to delay this process. In only 10–15% of MS patients a clinical
progression from the debut of the disease is observed, referred to as
primary progressive MS (PPMS).
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MS aetiology remains elusive, but the prevailing hypothesis
supports an underlying autoimmune process triggered by the
interplay of not fully described environmental and genetic factors.
The weight of either genetics or environment in the pathogenesisof
MS is a matter of debate [2]. In terms of environmental factors,
higher latitude has been reported to correlate with increased
prevalence of MS [3] probably driven by differences in sunlight
exposure and vitamin D levels [4,5], also repeatedly mentioned as
environmental factors related with the risk of developing MS [6].
In addition, several viruses have been considered as triggers of MS,
among them Epstein Barr virus [7,8], Herpes Simplex or human
herpesviruses [9], which could be key players in the disease
mediated through direct or indirect mechanisms.
The strongest genetic factor to date, the Human Leucocyte
Antigen (HLA) locuswas identified almost 40 years ago [10,11].
Subsequently, underpowered linkage and candidate gene associ-
ation studies determined a slow progress in the discovery of new
genetic risk factors. In the past five years, genome wide association
scans (GWAS) including thousands of patients and controls have
allowed an unprecedented increase in the list of predisposition
factors described for MS [12,13]. Nonetheless, the individual effect
of each variant is modest, with odds ratios ranging from 1.1 to 1.3.
Moreover, the overall results of this statistically powerful approach
account only partially for the MS heritability previously estimated
by epidemiological studies. Approximately 30% of the genetic
variation associated with MS is directly explained by variants
represented by current GWAS arrays [14]. However, one should
not forget that repetitive sequences of the genome skip the
scanning of GWAS. Considering the results of the recently
reported ENCODE project pointing to a pervasive transcription of
the whole genome [15], these repetitive sequences could be
potentially important to uncover part of the heritability not yet
ascribed in these complex diseases.
An 8% of the repetitive sequences in the genome correspond to
the so called human endogenous retroviruses (HERVs). They
derived from the exogenous retroviral infection of the germline at
different time points during evolution of the human lineage, and
have been transmitted in a Mendelian fashion [16]. HERVs can
be divided into distinct families, most of which resulted in multiple
integrations of phylogenetically related but structurally heteroge-
neous elements. Host-retrovirus interactions influence the genomic
landscape and have contributed substantially to mammalian
genome evolution [17]. Some of the HERV familieshave been
proposed to contribute to MS pathogenesis [18]. One of these
HERV insertions associated with MS risk is HERV-Fc1,
integrated about 10–15 million years ago [19]. Two subgroups
exist in this family, HERV-Fc1 with only one component located
in chromosome X and five related copies within the HERV-Fc2
subgroup. A polymorphism mapping close to the HERV-Fc1 copy
located in chromosome X, rs391745, was found associated with
MS in two out of the three Danish cohorts originally tested [20].
Then, further replication in a Norwegian cohort was achieved,
revealinga specific association with bout-onset MS clinical forms
[21]. Considering the mentioned effect of latitude on MS
prevalence, we aimed to replicate the association of the HERV-
Fc1 polymorphism rs391745 with relapsing remitting and
secondary progressive MS in three independent Spanish cohorts,
to ascertain whether the reported association is exclusive of higher
latitudes in Europe or else is a general MS risk factor.
Results
The first work providing genetic evidence for the involvement of
HERV-Fc1 in the aetiology of MS and published by Nexo et al
[20] studied the polymorphism rs391745 in three Danish cohorts:
the discovery cohort showed a strong association [OR
(95%CI) = 2.29 (1.60–3.28)], and from the two cohorts subse-
quently analyzed, one yielded replication [OR (95%CI) = 1.43
(1.09–1.89)] but the other did not evidenced association with MS
[OR (95%CI) = 1.01 (0.64–1.59)]. Later, the effect observed in
Danish MS samples was replicated in a Norwegian cohort [OR
(95%CI) = 1.35 (1–1.83)] [21]. However, considering the accepted
latitude gradient affecting MS prevalence, we aimed to validate
this effect in a population from Southern Europe and to meta-
analyze these results and those previously published (see Fig. S1
and Fig. S2).
A total of 2473 MS patients (see Table 1 for clinical data from
the three cohorts) and 3031 ethnically matched Spanish controls
were genotyped for rs391745 (Table 2). Genotyping success was
over 95% for all groups of patients and controls. No departure
from Hardy Weinberg equilibrium in the control groups was
observed.
As summarized in the forest plot depicted in Figure 1A, two out
of the three tested Spanish cohorts showed significant associations
of the rs391745*C-carriers with MS. However, in the cohort from
Southern Spain an effect of the opposite allele could be detected.
When heterogeneity was eliminated (I2 = 0%) by excluding this
latter South-Spanish cohort and the discovery Danish cohort from
Nexo et al [20], which was probably over estimated due to the so
called winner’s curse, the overall meta-analysisby Mantel-Haenszel
test evidenced a strong association [Fig. 1B; pM-H = 0.0005; ORM-
H (95%CI) = 1.27 (1.11–1.45)].
Additionally, the study by Hansen et al [21] that included part
of the already mentioned Danish cohorts, reported a specific effect
of this polymorphism in bout-onset MS; in contrast, lack of
association was claimed for the primary progressive clinical form.
In the present work (Figure 2), when validation was restricted to
relapsing remitting and secondary progressive MS samples from
the Spanish cohorts that did not show heterogeneity in the
previous overall analysis, a slight improvement in the association
was observed [Fig. 2B; pM-H = 0.0003; ORM-H (95% CI) = 1.32
(1.14–1.53)]. Moreover, concordantly with the previous results, the
pooled analysis of the primary progressive samples (n = 275) did
not seem to follow a similar trend for association [ORM-H (95%
CI) = 0.92 (0.63–1.34)], although a definitive conclusion was
hampered by statistical power limitations.
The stratified analysis by gender or HLA-DRB1*15:01 status
did not detect any additional effect (Table 2).
Discussion
The aim of this work was to validate the reported effect on MS
susceptibility of a bi-allelic polymorphism located near the HERV-
Fc1 insertion, rs391745, through genotyping of three independent
Spanish cohorts. In the Northern European populations previously
studied, this SNP located in chromosome X showed the most
significant association amongst the 80 SNPs genotyped within a
20 Kb associated region which includes the endogenous retrovirus
copy [20]. Environmental factors affecting MS have been recently
reviewed [22] and the latitude gradient seems to be the more
obvious, with a prevalence of MS oscillating more than 20 fold
from very low levels near equator 5–10:100000 to 200:100000 in
higher latitudes. In the present work, after a sensitivity analysis to
remove the heterogeneous cohorts (I2 = 0%), a significant overall
association was observed [pM-H = 0.0005; ORM-H (95% CI) = 1.27
(1.11–1.45)] suggestive of the role of the HERV-Fc1 insertion on
MS predisposition.
HERV-Fc1 Association with MS Risk: A Meta-Analysis
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The previously reported association was confirmed in cohorts
from Northern and Central Spain, but a significant effect of the
opposite allele was detected in the cohort from Southern Spain.
This finding, already described in the literature as ‘‘flip-flop
phenomenon’’ where significant associations for the same disease
occur at opposite alleles of the same polymorphism, has been
observed quite frequently [23]. Some authors hypothesized that
this phenomenon can occur due to variation in linkage disequi-
librium architecture [23], which is also present within the same
ethnic origin [24]; while others explain it through differences in
haplotypic frequencies [25]. Whatever the case, it has been proven
that the probability of randomly observing a significant allele flip
in samples ascertained similarly from a common population is
negligible [26]. From this standpoint, the inclusion of the Southern
Spanish cohort to the present meta-analysis considering associa-
tion of the opposite allele would provide similar results [I2 = 0%;
pM-H = 0.0002; ORM-H (95% CI) = 1.27 (1.12–1.45)].
As Figure 3 summarizes, rs391745 was not genotyped in the last
genome-wide association studies reported by the IMSGC-
WTCCC2 consortium [13]. Nonetheless, four SNPs localized
upstream to the HERV-Fc1 provirus showed association with MS
even though they did not reach the GWAS threshold for
significance (rs7881334, p = 0.002; rs402270, p = 0.005;
rs318177, p = 0.0004; rs2125324, p = 0.016). These SNPs show
high LD among them and their association with MS susceptibility
is indicative of the relevance of this locus, although rs391745
shows low LD with these SNPs (r2,0.47). The Immunochip study,
recently published in MS [27], was designed to deeply interrogate
184 non-MHC loci with genome-wide significant associations to at
least one autoimmune disease, but none of them map to
chromosome X where HERV-Fc1 is located, and therefore no
additional information could be incorporated from this source.
In parallel to the genetic factors already described for MS [13],
the effect now validated on MS predisposition is modest. This
could explain why the size of the cohorts led to a limited statistical
power to consistently detect the observed association and one of
the Danish cohorts originally tested did not show association with
HERV-Fc1 [OR (95%CI) = 1.01 (0.64–4.59)].
The proviral insertion of HERV-Fc1 in chromosome X presents
stop-codons and a frame-shift in the pol gene; however, the gag and
env genes are complete. A 4-fold increase in extracellular HERV-
Fc1 gag RNA titres has been described in patients with active MS
Table 1. Demographic characteristics of the MS patients included in the study.
Northern Spain Central Spain Southern Spain
Characteristics Patients Controls Patients Controls Patients Controls
Subjects (n) 569 980 883 692 1021 1359
Female (%) 73 46 66 55 68 69
HLA DRB1*15:01 (%) 42 25 38 11 38 18
Age (yrs) (Mean 6 SD) 42613 4469 45610 42617 44611 4469
Age at onset (yrs) (Mean 6 SD) 31610 _ 3069 _ 28611 _
Clinical form:
RR (n) 304 _ 653 _ 798 _
SP (n) 66 _ 61 _ 82 _
PP (n) 48 _ 61 _ 26 _
doi:10.1371/journal.pone.0090182.t001
Table 2. Genotype frequencies of rs391745 in the Spanish cohorts included in the study.
MS type CC CG GG
n (%) n (%) n (%)
Northern Spain MS (n = 569) Total 25 (4) 79 (14) 465 (82)
15:01+ 16 (7) 27 (11) 195 (82)
15:012 9 (3) 52 (16) 270 (81)
Controls (n = 980) Total 63 (6) 73 (7) 844 (86)
Central Spain MS (n = 883) Total 44 (5) 125 (14) 714 (81)
15:01+ 13 (4) 41 (13) 271 (83)
15:012 26 (5) 81 (15) 423 (80)
Controls (n = 692) Total 44 (6) 80 (12) 568 (82)
Southern Spain MS (n = 1021) Total 40 (4) 130 (13) 851 (83)
15:01+ 13 (6) 31 (13) 184 (81)
15:012 13 (4) 44 (12) 309 (84)
Controls (n = 1359) Total 71 (5) 208 (15) 1080 (80)
doi:10.1371/journal.pone.0090182.t002
HERV-Fc1 Association with MS Risk: A Meta-Analysis
PLOS ONE | www.plosone.org 3 March 2014 | Volume 9 | Issue 3 | e90182
compared with healthy controls [28], but no additional insertions
in other genomic contexts could be identified [29]. Further
functional studies are warranted to elucidate the exact mechanism
involved in the trigger of MS predisposition.
This new association transcends the boundaries of the
identification of an additional genetic risk factor for MS, its
location in a region of the genome overlooked by GWAS is highly
relevant to dispatch the widely held view that a big part of the
human genome constitutes mostly ‘‘junk DNA’’, an issue recently
illustrated by the ENCODE project [15]. The work now presented
encourages the screening of unexplored sequences harbouring
human endogenous retrovirus, as they could be at the crossroads
of genetics and environment [30]. Some interesting results in terms
of MS predisposition have been already published for HERV-W
[31], HERV-H [32] and HERV-K18 [33], supporting the
relevance of these endogenous retroviruses. A remaining challenge
for the search of susceptibility variants in complex diseases as MS
lies in populating these virgin territories by characterizing
repetitive sequences of the genome.
Materials and Methods
Patients
Three independent cohorts including a total of 2473 MS
patients and 3031 ethnically matched controls were consecutively
recruited from the following Spanish Hospitals: H. Clı´nico San
Carlos, Madrid (883 patients and 692 controls), H. Basurto, Bilbao
(569 patients and 980 controls) and from three Hospitals of
Andalucı´a: H. Regional Universitario, Ma´laga; H. Virgen
Macarena, Sevilla and H. Virgen de las Nieves, Granada (1021
patients and 1359 controls) (Table 1). MS Spanish patients were
diagnosed based on the McDonald criteria [34].
Ethics statement
All subjects were recruited after written informed consent and
the Ethics Committees of the participant hospitals approved this
study: CEIC (Ethics Committee of Clinical Investigation) from H.
Basurto (Bilbao), CEIC from H. Clı´nico San Carlos (Madrid),
CEIC from H. Regional Universitario (Ma´laga), CEIC from H.
Virgen Macarena (Sevilla), CEIC from C.S.I.C. and CEIC from
H. Virgen de las Nieves (Granada). All research was conducted
according to the principles expressed in the Declaration of
Helsinki.
Genotyping
DNA was extracted from peripheral blood by a standard salting
out method. The single nucleotide polymorphism rs391745 was
analyzed by Taqman technology using 384 well plates in a
7900HT Fast Real-Time PCR system, under the conditions
Figure 1. Meta-analysis including the studies of HERV-Fc1 association with MS published previously and those performed in the
Spanish cohorts. Forest plot showing the overall data (A) and after eliminating heterogeneity by removing the Southern Spanish cohort (B).
doi:10.1371/journal.pone.0090182.g001
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recommended by the manufacturer (Applied Biosystems, Foster
City, CA, USA).
Systematic review
We performed a comprehensive search strategy of various
electronic databases: MEDLINE (1966 - October 2013), Cochrane
Database of Systematic Reviews (1991- October 2013) and
EMBASE (1980- October 2013), by combining the terms:
‘‘HERV-Fc1’’, ‘‘HERV-F’’ and ‘‘rs391745’’. Additionally, a
manual search of all references was conducted among the
identified studies and relevant review articles. This search
rendered 20 articles published to date. Neither date nor language
restrictions were imposed. The association studies considered for
further analysis were required to hold information about rs391745
genotypesand consequently only two studies remained. Non-
published data from the Spanish cohorts described abovewere also
included (see Fig. S1 and Fig. S2).
Statistical analysis
Statistical analyses were performed with standard software
(SPSS v15 and Review Manager RevMan v. 5.0.). For the Mantel-
Haenszel analysis, Odds Ratios (ORs) and 95% confidence
intervals (CIs) were calculated by using raw data for each study
and for the pooled population. The Der Simonian and Laird
Figure 2. Meta-analysis of HERV-Fc1 association studies with bout-onset MS. Forest plot including all the available cohorts (A), and after
eliminating heterogeneity by removing the Southern Spanish cohort (B).
doi:10.1371/journal.pone.0090182.g002
Figure 3. Scheme of the HERV-Fc1 position and polymorphisms in the locus. The figure depicts from top to bottom: Chr X scale;
chromosomal position as indicated in B37/gh19 (Position); SNPs genotyped in the IMSGC-WTCCC2 GWAS (GWAS SNPs); statistically significant SNPs
with p#0.05 (Significant SNPs); position of rs391745 (Studied SNP); HERV-Fc1 retrovirus copy position (Virus Position) and common polymorphisms
mapping at this locus (Common SNPs).
doi:10.1371/journal.pone.0090182.g003
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random effects model was used according to the results of the tests
of heterogeneity. The combined effect for heterogeneity was
calculated by estimating the inverse variance, p value,0.10 and
the I2 statistic with a cut-off point of 25%, which define a
significant degree of heterogeneity between the studies. The effect
of each study was weighted for the total number of patients
included. A sensitivity analysis was performed to test the relative
influence of each study on the results. Studies were sequentially
dropped, and the effect on the change in the overall degree of
heterogeneity was determined.
Supporting Information
Figure S1 Preferred reported items for systematic
review and meta-analyses. PRISMA 2009 Checklist.
(TIF)
Figure S2 Preferred reported items for systematic
review and meta-analyses. PRISMA 2009 Flow Diagram.
(TIF)
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